Job Title: Sr Regulatory Professional
Department: Regulatory Affairs, Research & Development
Location: Novo Nordisk Global Business Services (GBS), Bangalore
As Sr Regulatory Professional, you will lead the regulatory strategy that moves Novo products through development, approval and lifecycle management worldwide. You will own submissions and Health Authority interactions, shape core labelling that reflects what makes a product different, and represent Regulatory Affairs in the Global Project Team. Your decisions will help determine how quickly and clearly new treatments reach people living with serious chronic diseases, and how reliably they stay available.
You are an experienced regulatory professional who can set strategy, negotiate with Health Authorities and keep complex global projects moving. You will bring:
You take personal leadership, adapt quickly when priorities change, spot problems early and make bold, well-founded decisions. You welcome honest feedback and enjoy helping others grow.
The role spans six areas, from global submissions and labelling to project leadership and commercial lifecycle management.
You will also step in for other Global Regulatory Leads when needed.
You will join Regulatory Affairs in Research & Development, where colleagues help advance scientific ideas towards clinical testing, approval and the people who need them. You would join the RA Diabetes team under Madhusudana Reddy S
Your closest partners will be the Global Project Team and the RQC Matrix Team you chair, including CMC, device and labelling specialists. Externally, you will be a key point of contact for Health Authorities worldwide, including in the EU, US, China and Japan.
In this role, you create clarity across functions: flagging progress, risks and issues early, so teams can decide and move forward at pace.
You will work at the centre of global development and lifecycle decisions, building new skills across the R&D value chain through work with functions and Health Authorities around the world. You will be trusted to own your development and make your voice heard in the decisions that shape each project.
You will also help others be their best – onboarding, job-shadowing and mentoring new colleagues, and contributing to team and department engagement.
Your impact begins today. If you are ready to lead the regulatory strategy that brings new treatments to people worldwide, apply for the Sr Regulatory Professional role by 28 October 2026.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health.
Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com.
This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in:
https://www.novonordisk.com/contact-us/find-local-information.html
For other customer complaints, please contact us here:
https://www.novonordisk.com/contact-us.html
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed.
Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.
Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html